Admissions and Bed Days
Outcomes achieved using a digital service model for COPD
Admissions and bed days were both cut in half at 1 year survival in the RECEIVER group with these participants matched to a control reference population.
Let's look at what that means when considering how Lenus can transform the traditional COPD pathway.
How the Lenus Service has reduced admissions and occupied bed days for users
Reduction in admissions
Annual bed days saved per patient
More information on the data visualised
Control cohort criteria.
Alive for 12-months post-index date.
RECEIVER cohort criteria.
Alive 12-months post-onboarding date.
|Event Criteria||Combined occupied bed day (OBD) count from respiratory-related hospital admissions starting over a 12-month period.|
Year prior: OBDs from admissions starting between onboarding/index dates and 365-days prior to this.
Year following: admissions starting 1-day post-index/onboarding date and 365-days after this.
- The annotated points show the mean number of occupied bed days had over each window with the distribution of values observed at each time point shown by the violin plots and overlaid boxplots.
- The reduction in OBDs seen in the control cohort has been widely reported across populations with COPD during the COVID-19 response period.
- Notably, a substantially higher reduction in OBDs was observed in the RECEIVER cohort and controlled by comparing the mean difference in each cohort for year prior and year after.
ClinicalTrials.gov Identifier: NCT04240353
The feasibility and service adoption observational cohort RECEIVER trial was commenced in September 2019 by NHS Greater Glasgow and Clyde to evaluate the implementation and efficacy of the Lenus COPD Service with high-risk COPD participants matched 1:5 to a control cohort using de-identified contemporary routine clinical data. In March 2021, 'RECEIVER' recruitment was paused and a 'Dynamic-Scot' cohort was established through remote recruitment in the Covid-19 service scale-up to routine care. The protocol is published here with the full results available here.
|Control||RECEIVER||Dynamic-Scot 1||Service users|
Selected from the NHS Greater Glasgow and Clyde SafeHaven dataset.
Diagnosis of COPD + a COPD-related hospital admission within a 14-day window of a reference RECEIVER trial participant's onboarding date were criteria for entry.
From these criteria, the optimal ~5 matches for each RECEIVER participant were determined based on sex and age whilst excluding duplicate control patients or individuals subsequently onboarded to Lenus COPD.
|At least one severe COPD exacerbation in the year prior to onboarding to Lenus COPD and/or chronic hypercapnic respiratory failure/sleep disordered breathing requiring NIV/CPAP treatment.||Onboarded at least 365 days before 31/08/2021 (the data censor date for analyses).||RECEIVER and Dynamic-Scot 1 participants.|
|1st Participant Index Date||3rd September 2019||3rd September 2019||15th May 2020||3rd September 2019|
|Censor Date||31st August 2021|
Medtech Innovation Briefing
The National Institute of Health and Care Excellence (NICE) has developed a medtech innovation briefing (MIB) on Lenus COPD Support Service for remotely managing chronic obstructive pulmonary disease available here.
Get in touch
Got a service in mind for Lenus? Talk to us today.